Evidence map›Paper›PMID 35403296›Full record

Trial reportJournal of clinical laboratory analysis2022

Effect of vitamin D on oxidative stress and serum inflammatory factors in the patients with type 2 diabetes.

Jie-Chao Gu, Yue-Guan Wu, Wei-Gang Huang, Xiu-Jing Fan, Xin-Hao Chen, Biao Zhou, Zhi-Jun Lin, Xiu-Lan Feng

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical laboratory analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Vitamin D Alleviates Type 2 Diabetes Mellitus by Mitigating Oxidative Stress-Induced Pancreatic β-Cell Impairment.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jie-Chao GuDepartment of Laboratory Medicine, The People's Hospital of Jiangmen, Jiangmen, China.
Yue-Guan WuDepartment of Endocrinology, The People's Hospital of Jiangmen, Jiangmen, China.
Wei-Gang HuangDepartment of Laboratory Medicine, The People's Hospital of Jiangmen, Jiangmen, China.
Xiu-Jing FanDepartment of Laboratory Medicine, The People's Hospital of Jiangmen, Jiangmen, China.
Xin-Hao ChenDepartment of Laboratory Medicine, The People's Hospital of Jiangmen, Jiangmen, China.
Biao ZhouDepartment of Laboratory Medicine, The People's Hospital of Jiangmen, Jiangmen, China.
Zhi-Jun LinDepartment of Laboratory Medicine, The People's Hospital of Jiangmen, Jiangmen, China.
Xiu-Lan FengDepartment of Blood Transfusion, The People's Hospital of Jiangmen, Jiangmen, China.ORCID https://orcid.org/0000-0003-3458-1635
Jiangmen Central Hospital · CN

Funding

Bureau of Science and Technology of Jiangmen Municipality 2020YLC030
6 · The paper itself

Abstract

The type 2 diabetes mellitus (T2DM) is an urgent global health problem. T2DM patients are in a state of high oxidative stress and inflammation. Vitamin D and glutathione (GSH) play crucial roles in antioxidation and anti-inflammation. However, T2DM patients have lower vitamin D and GSH levels than healthy persons. A randomized controlled trial was conducted to see the effect of the vitamin D supplementation on oxidative stress and inflammatory factors in T2DM patients. In this study, a total of 178 T2DM patients were randomly enrolled, 92 patients received regular treatment (T2DM group) and 86 patients in Vitamin D group received extra vitamin D 400 IU per day in addition to regular treatment. Serum vitamin D, GSH, GSH metabolic enzyme GCLC and GR, inflammatory factor MCP-1, and IL-8 levels were investigated. We found that the T2DM group has significantly higher concentrations of MCP-1 and IL-8 than those in the healthy donor group. After vitamin D supplementation for 90 days, T2DM patients had a 2-fold increase of GSH levels, from 2.72 ± 0.84 to 5.76 ± 3.19 μmol/ml, the concentration of MCP-1 decreased from 51.11 ± 20.86 to 25.42 ± 13.06 pg/ml, and IL-8 also decreased from 38.21 ± 21.76 to 16.05 ± 8.99 pg/ml. In conclusion, our study demonstrated that vitamin D could regulate the production of GSH, thereby reducing the serum levels of MCP-1 and IL-8, alleviating oxidative stress and inflammation, providing evidence of the necessity and feasibility of adjuvant vitamin D treatment among patients with T2DM. On the other hand, vitamin D and GSH levels have important diagnostic and prognostic values in T2DM patients.

Indexed as

Diabetes Mellitus, Type 2Vitamin DDietary SupplementsGlutathioneHumansInflammationInterleukin-8Oxidative StressVitaminsGlutathioneInterleukin-8Vitamin DVitaminsglutathioneoxidative stressserum inflammatory factorstype 2 diabetesvitamin D

Identifiers

PMID35403296
PMCPMC9102501
OpenAlexW4223480139

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.